Ferrostatin-1 and hinokitiol supplementation enhance human hematopoietic stem cell expansion in a chemically defined

Lushen Li1, Pankaj K Mandal1

  • 1Tumor Vaccine and Biotechnology Branch, Division of Cell Therapy 2, Office of Cellular Therapy and Human Tissue, Office of Therapeutic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

Molecular Therapy. Advances
|May 15, 2026
PubMed

An optimized and standardized method for ex vivo expansion of cord blood (CB) hematopoietic stem cells (HSCs) in a chemically defined medium has yet to be established. In this study, we aimed to improve ex vivo expansion of HSCs in a recently developed cytokine-free, chemically defined 3a medium. We found that the co-supplementation of the ferroptosis inhibitor ferrostatin-1 and iron chelator hinokitiol (FHK) in 3a medium significantly improves CB HSC expansion by suppressing lipid peroxidation and mitigating oxidative stress. FHK supplementation improves overall cell proliferation and promotes preferential expansion of HSCs without adversely affecting the clonogenic, engraftment, and differentiation potential of HSCs. The delayed engraftment kinetics with gradual increase in hematopoietic output further suggests that FHK treatment may preserve or expand long-term HSCs. Our findings are in alignment with recent published studies highlighting the susceptibility of HSCs to ferroptosis and corroborate the use of antioxidants to improve ex vivo expansion of HSC.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...